Invesco’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $307M | Buy |
579,241
+1,667
| +0.3% | +$769K | 0.02% | 580 |
|
|
2026
Q1 | $277M | Buy |
577,574
+94,949
| +20% | +$48.6M | 0.03% | 574 |
|
|
2025
Q4 | $271M | Sell |
482,625
-54,782
| -10% | -$31.1M | 0.03% | 554 |
|
|
2025
Q3 | $276M | Buy |
537,407
+85,517
| +19% | +$37.3M | 0.04% | 523 |
|
|
2025
Q2 | $142M | Sell |
451,890
-734,878
| -62% | -$221M | 0.02% | 735 |
|
|
2025
Q1 | $362M | Buy |
1,186,768
+102,015
| +9% | +$34.3M | 0.07% | 377 |
|
|
2024
Q4 | $360M | Buy |
1,084,753
+519,186
| +92% | +$176M | 0.07% | 382 |
|
|
2024
Q3 | $189M | Sell |
565,567
-241,408
| -30% | -$91.7M | 0.04% | 620 |
|
|
2024
Q2 | $332M | Sell |
806,975
-8,826
| -1% | -$3.5M | 0.07% | 364 |
|
|
2024
Q1 | $330M | Buy |
815,801
+92,563
| +13% | +$32.5M | 0.07% | 378 |
|
|
2023
Q4 | $222M | Buy |
723,238
+111,338
| +18% | +$30.1M | 0.05% | 503 |
|
|
2023
Q3 | $148M | Buy |
611,900
+246,775
| +68% | +$63.1M | 0.04% | 594 |
|
|
2023
Q2 | $87.7M | Sell |
365,125
-18,966
| -5% | -$3.94M | 0.02% | 758 |
|
|
2023
Q1 | $72.2M | Sell |
384,091
-207,654
| -35% | -$42.9M | 0.02% | 821 |
|
|
2022
Q4 | $126M | Sell |
591,745
-138,516
| -19% | -$27.7M | 0.04% | 620 |
|
|
2022
Q3 | $115M | Sell |
730,261
-62,822
| -8% | -$10M | 0.04% | 613 |
|
|
2022
Q2 | $119M | Sell |
793,083
-100,941
| -11% | -$14.6M | 0.04% | 629 |
|
|
2022
Q1 | $146M | Sell |
894,024
-91,906
| -9% | -$15.2M | 0.04% | 628 |
|
|
2021
Q4 | $215M | Buy |
985,930
+57,837
| +6% | +$12.1M | 0.05% | 496 |
|
|
2021
Q3 | $176M | Buy |
928,093
+602
| +0.1% | +$110K | 0.04% | 569 |
|
|
2021
Q2 | $164M | Buy |
927,491
+28,274
| +3% | +$4.88M | 0.04% | 621 |
|
|
2021
Q1 | $148M | Buy |
899,217
+55,437
| +7% | +$8.48M | 0.04% | 619 |
|
|
2020
Q4 | $117M | Buy |
843,780
+9,447
| +1% | +$1.19M | 0.03% | 657 |
|
|
2020
Q3 | $93.2M | Buy |
834,333
+86,433
| +12% | +$9.99M | 0.03% | 665 |
|
|
2020
Q2 | $69.6M | Buy |
747,900
+182,434
| +32% | +$15.5M | 0.02% | 761 |
|
|
2020
Q1 | $41.5M | Sell |
565,466
-31,692
| -5% | -$2.75M | 0.02% | 885 |
|
|
2019
Q4 | $50.2M | Buy |
597,158
+26,827
| +5% | +$2.08M | 0.02% | 1014 |
|
|
2019
Q3 | $47.9M | Sell |
570,331
-23,423
| -4% | -$1.77M | 0.01% | 1013 |
|
|
2019
Q2 | $38.8M | Buy |
593,754
+260,980
| +78% | +$15M | 0.01% | 1130 |
|
|
2019
Q1 | $19.6M | Sell |
332,774
-101,051
| -23% | -$6.04M | 0.01% | 1237 |
|
|
2018
Q4 | $23M | Buy |
433,825
+371,782
| +599% | +$20.4M | 0.01% | 1091 |
|
|
2018
Q3 | $3.72M | Buy |
62,043
+28,378
| +84% | +$1.55M | ﹤0.01% | 2343 |
|
|
2018
Q2 | $1.45M | Sell |
33,665
-1,128
| -3% | -$45.6K | ﹤0.01% | 2948 |
|
|
2018
Q1 | $1.21M | Buy |
34,793
+22,578
| +185% | +$825K | ﹤0.01% | 2938 |
|
|
2017
Q4 | $443K | Buy |
12,215
+150
| +1% | +$5.26K | ﹤0.01% | 3347 |
|
|
2017
Q3 | $385K | Buy |
12,065
+701
| +6% | +$21.4K | ﹤0.01% | 3381 |
|
|
2017
Q2 | $330K | Sell |
11,364
-15,925
| -58% | -$447K | ﹤0.01% | 3456 |
|
|
2017
Q1 | $814K | Sell |
27,289
-88,520
| -76% | -$2.86M | ﹤0.01% | 3140 |
|
|
2016
Q4 | $4.18M | Sell |
115,809
-6,588
| -5% | -$219K | ﹤0.01% | 2093 |
|
|
2016
Q3 | $3.65M | Buy |
+122,397
| New | +$3.57M | ﹤0.01% | 2174 |
|
Other funds holding MEDP
WA
Invesco's MEDP Position: Q2 2026 in Review
Invesco increased its Medpace (MEDP) stake by 0.29% in Q2 2026, buying an estimated $769K and bringing the position to 579,241 shares worth $307M. The position accounts for 0.02% of the portfolio, ranked #580.
Invesco first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $362M in Q1 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Invesco held 579,241 shares of Medpace worth $307M as of Q2 2026.
- Invesco bought 1,667 Medpace shares in Q2 2026, an estimated $769K.
- Medpace made up 0.02% of Invesco's portfolio in Q2 2026, its #580 holding.
- Invesco first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Invesco's Medpace position peaked at $362M in Q1 2025.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.